Andrew Reaume
Chief Executive Officer at Melior Discovery, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Amy DiCamillo | F | - |
Melior Discovery, Inc.
 Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | - |
| Vera King Farris | M | 87 |
University of Pennsylvania
| 21 years |
| John Jeffrey Ying | M | 62 |
University of Pennsylvania
| 21 years |
| John A. Gruner | M | - |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | - |
| Angela Batman | F | - |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | - |
| Patty Ferrante | F | - |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | 17 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Amir Memon | M | - |
University of Pennsylvania
| 11 years |
| Michael E. Lewis | M | 72 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 5 years |
| Robert P. Roche | M | 68 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 15 years |
| Mary E. Olson | F | - |
University of Connecticut
| 6 years |
| Michael S. Saporito | M | - |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | - |
| Heather Hain | M | - |
Melior Discovery, Inc.
Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | - |
| Mark C. Boelhouwer | M | - |
University of Connecticut
| 2 years |
| John Dawson | M | 64 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 11 years |
| Eric Klein | M | - |
University of Pennsylvania
| 11 years |
| Nehal Kamalapat Chopra | F | - |
University of Pennsylvania
| 4 years |
| Ajim Tamboli | M | 47 |
University of Pennsylvania
| 8 years |
| John W. Glomb | M | - |
University of Pennsylvania
| 12 years |
| Darius Beni Cayetano | M | 50 |
University of Pennsylvania
| 11 years |
| Ari Levine | M | 41 |
University of Pennsylvania
| 4 years |
| Noah G. Schwartz | M | - |
University of Connecticut
| 6 years |
| Simón Gaviria Muñoz | M | 43 |
University of Pennsylvania
| 4 years |
| Robert Doebele | M | 53 |
University of Pennsylvania
| 4 years |
| Eric Zoller | M | - |
University of Pennsylvania
| 7 years |
| Puja Dhanraj | F | - |
University of Pennsylvania
| 5 years |
| Tai San Noah Lim | M | 49 |
University of Pennsylvania
| 3 years |
| Tim Heaney | M | - |
University of Connecticut
| 7 years |
| John Fry | M | 64 |
University of Pennsylvania
| 7 years |
| John E. Osborn | M | 66 |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 11 years |
| Jeff Bianchi | M | - |
University of Connecticut
| 5 years |
| Christopher Patusky | M | 60 |
University of Pennsylvania
| 7 years |
| Taran Sang Yong Bae | M | - |
University of Pennsylvania
| 2 years |
| Kailash Birmiwal | M | - |
University of Connecticut
| 8 years |
| Mark Militello | M | - |
University of Connecticut
| 8 years |
| Thuy Tran | M | - |
University of Pennsylvania
| 2 years |
| Pete Kim | M | 50 |
University of Pennsylvania
| 2 years |
| Roger Egan | M | - |
University of Pennsylvania
| 4 years |
| Nadav Besner | M | 44 |
University of Pennsylvania
| 4 years |
| Devesh Sharad Gandhi | M | - |
University of Pennsylvania
| 2 years |
| Douglas Winston Kennedy | M | - |
University of Pennsylvania
| 4 years |
| Victor S. Gill | M | - |
University of Pennsylvania
| 4 years |
| Brian Propes | M | - |
University of Pennsylvania
| 2 years |
| Ryan McKenna | M | - |
University of Pennsylvania
| 4 years |
| Charles Rayner | M | - |
University of Pennsylvania
| 4 years |
| Oren Isacoff | M | 40 |
University of Pennsylvania
| 4 years |
| Omar Al-Madhi | M | - |
University of Pennsylvania
| 2 years |
| Zeynep Lucchini Gilera | F | - |
University of Pennsylvania
| 4 years |
| Sonalie Figueiras | M | - |
University of Pennsylvania
| 4 years |
| Daniel Northrup | M | - |
University of Pennsylvania
| 5 years |
| Gabriel Schneider | M | - |
University of Pennsylvania
| 4 years |
| Shelby Zitelman | F | - |
University of Pennsylvania
| 4 years |
| Julia Hu | F | - |
University of Pennsylvania
| 2 years |
| Peter A. Christodoulou | M | - |
University of Pennsylvania
| 4 years |
| Richard Pulik | M | - |
University of Pennsylvania
| 4 years |
| Alex Abrams | M | - |
University of Pennsylvania
| 4 years |
| Veronica Zapasnik | F | - |
University of Pennsylvania
| 4 years |
| CHALAL ISAAC S | M | - |
University of Pennsylvania
| 4 years |
| Vinay Singh | M | - |
University of Pennsylvania
| 4 years |
| Paul Kim | M | - |
University of Pennsylvania
| 8 years |
| Sean Brecker | M | 49 |
University of Pennsylvania
| 2 years |
| Jenna Foger | F | - |
University of Pennsylvania
| 4 years |
| Dan Wadhwani | M | - |
University of Pennsylvania
| 7 years |
| Ignacio M. DuQuesne | M | - |
University of Pennsylvania
| 4 years |
| Linda Huynh | F | - |
University of Pennsylvania
| 4 years |
| Kiel Berry | M | - |
University of Pennsylvania
| 4 years |
| Barry D. Greenberg | M | - |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | 4 years |
| Phil Engel | M | - |
University of Pennsylvania
| 4 years |
| Jennifer H. Hartt | F | - |
University of Pennsylvania
| 5 years |
| Russell Myer Hoffman | M | - |
University of Pennsylvania
| - |
| Sandy Khaund | M | - |
University of Pennsylvania
| 2 years |
| Ian Foley | M | - |
University of Pennsylvania
| 4 years |
| Xin Liu | F | - |
University of Pennsylvania
| 2 years |
| Luciano Toledo de Campos | M | - |
University of Pennsylvania
| 2 years |
| Lloyd Sommers | M | - |
University of Pennsylvania
| 4 years |
| Lily Ng | F | - |
University of Pennsylvania
| 4 years |
| Matt Q. Reber | M | - |
University of Pennsylvania
| 2 years |
| Christopher Sighinolfi | M | 40 |
University of Pennsylvania
| 4 years |
| Matthew Satnick | M | 44 |
University of Pennsylvania
| 4 years |
| Adam Fishman Zimbler | M | - |
University of Pennsylvania
| 2 years |
| D. J. Andrzejewski | M | - |
University of Pennsylvania
| 4 years |
| Russell D. Gehrett | M | - |
University of Pennsylvania
| 4 years |
| Wen Kai Xiang | M | - |
University of Pennsylvania
| 4 years |
| Evren D. Kopelman | F | - |
University of Pennsylvania
| 2 years |
| Laura Holson | F | 38 |
University of Pennsylvania
| 4 years |
| Atul Joshi | M | - |
University of Pennsylvania
| 4 years |
| Melanie L. Lorenzo | F | 44 |
University of Pennsylvania
| 3 years |
| Kyle Rhoades | M | - |
University of Pennsylvania
| 4 years |
| Jonathan Hirschtritt | M | - |
University of Pennsylvania
| 4 years |
| Sunitha Thomas | F | - |
University of Pennsylvania
| 2 years |
| Arun Rao | M | - |
University of Pennsylvania
| 4 years |
| Anthony Cambeiro | M | - |
University of Pennsylvania
| 4 years |
| Gor Ter-Grigoryan | M | - |
University of Pennsylvania
| 4 years |
| Omar Elangbawy | M | - |
University of Pennsylvania
| 4 years |
| Jason E. Lee | M | - |
University of Pennsylvania
| 4 years |
| Sabir J. Rassiwalla | M | - |
University of Pennsylvania
| 4 years |
| Antonia Ness | F | - |
University of Pennsylvania
| 1 years |
| Jonathan Goldstein | M | - |
University of Pennsylvania
| 3 years |
| Jeremy Becker | M | - |
University of Pennsylvania
| 4 years |
| Eric Ostertag | M | 51 |
University of Pennsylvania
| 13 years |
| Eric D. Grossman | M | - |
University of Pennsylvania
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andrew Reaume
- Personal Network
